The objective of the current study was to evaluate the effectiveness of intramammary infusion of a recombinant interleukin 8 as a therapy to resolve chronic subclinical mastitis by decreasing the SCC and improving neutrophil phagocytic response. Here, CXCL8 is linked to mastitis.